SCHEMBL905708

SCHEMBL905708

CC(=O)SS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL6550823 0.89 FFAR3 (0.40)
SCHEMBL7485807 0.67
SCHEMBL4888525 0.67
SCHEMBL181825 0.67
SCHEMBL479385 0.67
SCHEMBL223006 0.67
SCHEMBL394702 0.67
SCHEMBL735595 0.67
SCHEMBL3182198 0.67
SCHEMBL8947 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119842244-A Self-diagnosis self-healing polyurethane modified asphalt and preparation method and application thereof 江苏苏博特新材料股份有限公司 2025-04-18 CN claimed
US-9169286-B2 Use of N-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide AGILENT TECHNOLOGIES, INC. (US) 2015-10-27 US claimed
US-20130035261-A1 USE OF N-ALKYL IMIDAZOLE FOR SULFURIZATION OF OLIGONUCLEOTIDES WITH AN ACETYL DISULFIDE AGILENT TECHNOLOGIES, INC. (US) 2013-02-07 US claimed
US-8309710-B2 Use of N-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide AGILENT TECHNOLOGIES, INC. (US) 2012-11-13 US claimed
EP-2277886-B1 The use of n-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide AGILENT TECHNOLOGIES INC (US) 2012-10-24 EP claimed
EP-2277886-A1 The use of n-alkyl imidazole for sulfurization of oligonucleotides with an acetyl disulfide Agilent Technologies, Inc. (US) 2011-01-26 EP claimed
US-20100331532-A1 Use Of N-Alkyl Imidazole For Sulfurization Of Oligonucleotides With An Acetyl Disulfide AGILENT TECHNOLOGIES, INC. 2010-12-30 US claimed
US-7227015-B2 Synthesis of sulfurized oligonucleotides ISIS PHARMACEUTICALS, INC. (US) 2007-06-05 US claimed
US-20050165226-A1 Synthesis of sulfurized oligonucleotides ISIS PHARMACEUTICALS INC. 2005-07-28 US claimed
EP-1023310-B1 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2004-12-08 EP claimed
US-20030212267-A1 Synthesis of sulfurized oligonucleotides IONIS PHARMACEUTICALS, INC. 2003-11-13 US claimed
EP-1246833-A4 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2003-04-09 EP claimed
EP-1246833-A1 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2002-10-09 EP claimed
WO-2001051502-A1 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2001-07-19 WO claimed
US-6242591-B1 Synthesis of sulfurized 2'-substituted oligonucleotides ISIS PHARMACEUTICALS, INC. 2001-06-05 US claimed
EP-1023310-A4 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2001-05-16 EP claimed
EP-1023310-A1 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2000-08-02 EP claimed
WO-1999019340-A1 IMPROVED SYNTHESIS OF SULFURIZED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 1999-04-22 WO claimed
US-12503698-B2 GalNAc derivatives Janssen Pharmaceuticals, Inc. (US) 2025-12-23 US disclosed
US-3970561-A Separation of compounds differing in isotopic composition SIEVERS ROBERT E 1976-07-20 US disclosed